These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15826414)

  • 21. Screening for prostate cancer.
    Raffle AE
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):484, 486. PubMed ID: 10193448
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate cancer screening with PSA: "Aequanimitas".
    Sadi MV
    Int Braz J Urol; 2013; 39(4):447-53. PubMed ID: 24054394
    [No Abstract]   [Full Text] [Related]  

  • 23. Is a screening interval of every 4 years for prostate cancer acceptable?
    Crawford ED
    J Natl Cancer Inst; 2007 Sep; 99(17):1279-80. PubMed ID: 17728212
    [No Abstract]   [Full Text] [Related]  

  • 24. New Zealand should introduce population screening for prostate cancer using PSA testing: yes.
    Smart R
    J Prim Health Care; 2009 Dec; 1(4):319-20. PubMed ID: 20690342
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer and PSA screening.
    Mameghan H
    Aust Fam Physician; 1999 Aug; 28(8):777-81. PubMed ID: 10495525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
    Loeb S; Catalona WJ
    Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
    [No Abstract]   [Full Text] [Related]  

  • 29. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for early prostate cancer: what is the problem?
    Moffat L
    J R Coll Surg Edinb; 2000 Apr; 45(2):127-31. PubMed ID: 10822923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostate-specific antigen and prostate cancer prognosis.
    Church TR
    J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
    [No Abstract]   [Full Text] [Related]  

  • 33. Demand for prostate specific antigen testing in primary care. Screening through back passage as well as back door?
    Hopcroft K
    BMJ; 2002 Mar; 324(7336):547. PubMed ID: 11872566
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer screening "reloaded".
    Gomella LG
    Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
    Roussel B; Ouellet GM; Mohile SG; Dale W
    Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
    Roobol MJ; Schröder FH
    J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
    [No Abstract]   [Full Text] [Related]  

  • 37. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 38. Storm over screening for prostate specific antigen. Give men facts on prostate cancer.
    Darracott Vaughan E; McLeod DG
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12053924
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening for prostate cancer.
    Malone P
    Ann R Coll Surg Engl; 2005 Mar; 87(2):88-9. PubMed ID: 16790126
    [No Abstract]   [Full Text] [Related]  

  • 40. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.